Medicure : Q1 - March 31, 2024 - MarketScreener

Condensed Consolidated Interim Financial Statements





MEDICURE INC.


Three months ended March 31, 2024


...

Related Keywords

Canada ,Puerto Rico ,Guam ,United States ,Toronto ,Ontario ,Canadian ,American , ,International Financial Reporting Standards ,Drug Administration ,Medicure Inc ,Exchange Commission ,Medicure International Inc ,Marley Drug Inc ,Cadila Healthcare Ltd ,National Instruments ,International Accounting Standards Board ,Venture Exchange ,Toronto Stock Exchange ,American Stock Exchange ,International Financial Reporting Interpretations Committee ,Medicure Pharma Inc ,International Accounting Standard ,Company Common ,Canadian Dollars ,Canadian Securities Administrators ,Consolidated Interim Statements ,Financial Position ,Net Income ,Comprehensive Income ,Cash Flows ,Common Shares ,Toronto Stock ,Medicure International ,Medicure Pharma ,Marley Drug ,Financial Reporting ,Sensible Medical ,Mail Order Pharmacy ,